About Centile Bio
Centile Bio is a private company based in Bethesda, Maryland, incorporated in 2023 in Delaware. It has reported $3,054,996 raised in one offering on Form D since April 2026. Its chief executive is Jakob Seidlitz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 20, 2026 | Apr 16, 2026 | $3,054,996of $4.0M target | 3 | $1.0M | Equity, Convertible securitiesRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Centile Bio's Form D filed Apr 16, 2026.
